Continuous administration of GnRH-
## **Core Concept**
The administration of Gonadotropin-Releasing Hormone (GnRH) plays a crucial role in regulating the reproductive endocrine system. GnRH acts on the anterior pituitary gland to stimulate the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn regulate ovarian and testicular function.
## **Why the Correct Answer is Right**
Continuous administration of GnRH leads to **downregulation** and **desensitization** of GnRH receptors in the anterior pituitary gland. This results in a decrease in the secretion of LH and FSH. The initial surge in LH and FSH levels is followed by a sustained decrease, effectively suppressing gonadotropin release. This mechanism is utilized clinically to treat conditions like prostate cancer, endometriosis, and precocious puberty.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because continuous GnRH administration does not lead to a sustained increase in LH and FSH levels; instead, it causes downregulation and a subsequent decrease.
- **Option B:** This option is incorrect because, although GnRH does stimulate the release of LH and FSH, continuous administration leads to desensitization, not a sustained stimulatory effect.
- **Option C:** This option might seem plausible due to the initial effect of GnRH, but it does not accurately reflect the outcome of continuous administration.
## **Clinical Pearl / High-Yield Fact**
A key clinical application of continuous GnRH administration is in the treatment of **hormone-sensitive cancers**, such as prostate cancer, where reducing testosterone levels can slow tumor growth. Another important use is in **assisted reproduction**, where GnRH agonists are used to prevent premature LH surges, allowing for better control of ovulation.
## **Correct Answer:** . Decreases LH and FSH secretion.